series | patient group | n | treatment | median overall survival (months) | 2-year overall survival | reference |
---|---|---|---|---|---|---|
NOA-01 | all GBM | 154 | post-OP RT + ACNU/VM26 | 17.3 | 25% | [7] |
EORTC 26981 | all GBM | 287 | post-OP RT + TEM | 14.6 | 26.5% | [5] |
RTOG 83-02 | GBMO | 23 | post-OP RT + BCNU | 14.3 | (3-year survival: 35%) | [4] |
retrospective | GBMO | 12 | resection + RT, chemo in 2/12 | 26 | 58% (data taken from graph) | [8] |
retrospective | GBMO | 11 | post-OP RT in 65% (total group) | 17.7 | 20% (data taken from graph) | [18] |
retrospective | GBMO | 5 | post-OP RT in 80% | 16.2 | n. a. | [19] |
present series | GBMO | 10 | post-OP RT + ACNU/VM26 (8/10) | 26 | 60% |